Investors Haven’t Figured Out There’s a $4 Trillion Global Cannabis Opportunity Unfolding

Starting around 1913 or so, world governments were gripped with a kind of mania to ban cannabis. Jamaica, Mexico, South Africa, Canada… and on and on.

In 1925, the League of Nations revised the International Opium Convention to target the global trade in cannabis for the first time.

And in 1937, the United States’ Marijuana Tax Act of 1937 effectively banned cannabis at the federal level here.

So in America alone, we’ve had more than 80 years of prohibition.

That’s why I’m so impressed with how far cannabis has progressed here; the pace has been relentless. Marijuana is legal in some form or another in all but nine states.

But there’s a big world of cannabis investing out there; globally, even in countries that have had prohibition just as long as we have, things are moving fast.

Let’s look at some firms that are already branching out into “global cannabis”…

First America, Then the World…

My readers had the chance to book a 90% profit in Curaleaf Holdings Inc. (OTCMKTS: CURLF) – a company that now brings in more revenue from selling cannabis than any other firm on the planet.

They made 188% on a recommendation for the one company fighting to carve out the biggest share of the soaring CBD market; in just three months, they had a shot at 109% on Cresco Labs Inc. (OTCMKTS: CRLBF), which my research shows will be a leading U.S. cannabis company.

CHECK THIS OUT: We’ve got six cannabis IPO recommendations ready to go – each with its own IPO dossier that hedge funds and venture capitalists would happily pay $30,000 or more for. Learn how to get access here.

These are the companies driving the cannabis revolution forward in America.

And the companies already in the global game, no matter their current market share, will have the “fuel” to launch their stocks into the stratosphere.

Back in May, I talked about the lead established by Canadian licensed producers in European cannabis markets.

Because of the legal clarity in Canada, Canada-based cannabis firms have wide leeway to build a portfolio of global assets. Using this legal head start, (and big balance sheets, flush with cash), these companies have worked quickly to acquire assets throughout Europe.

Cannabis legalization continues advancing in Europe, though at a slower pace than in the United States. It’s virtually all medical-use only, though tiny Luxembourg has confirmed it will legalize recreational use.

Interestingly – and contrary to popular American perceptions – cannabis is quite illegal in the Netherlands. Illegal, but “gedogen” – tolerated – and largely decriminalized. It’s widely sold and consumed in “coffee shops,” but it’s illegal for coffee shop owners to buy their own supply of marijuana. However, once they do buy it and bring it to their premises, sales of small amounts – five grams or less – are legal. Police can and occasionally do confiscate personal-use supplies, but most seizures occur in vehicles or near border areas.

The truth is, Dutch police have long turned a blind eye toward these “small-time” deals, since the 1960s.

But the Dutch are rolling out a legal experiment in 10 cities where nationally approved growers can cultivate cannabis legally to supply coffee shop owners. In these cities, the cops will then crack down on black-market sales to coffee shop owners.

Consider this a tentative step in the right direction.

But these two companies aren’t waiting for the dominoes to fall.

Give Yourself a Head Start on Cannabis Exports

Among the Canadian companies making moves in Europe is MPX International Corp. (OTCMKTS: MPXOF).

It just acquired a cannabis company based in Malta that gives it the ability to produce cannabis oils and cannabis derivative products, plus the ability to distribute regulated medical cannabis in Europe and Africa.

TerrAscend Corp. (OTCMKTS: TRSSF) is another Canadian L.P. making moves internationally. I consider TerrAscend one of the premier operators in both the United States. and Canada.

GET FULL ACCESS: You can read more about TerrAscend – and see our ranking system and proprietary analytics for more than 160 cannabis stocks. Learn how here

It controls assets that give it profitable operations at every step in the cannabis vertical, from cultivation to pharmaceuticals to hemp products. It is also the only cannabis company licensed to sell cannabis in the United States, Canada, and Europe.

It recently completed its first international shipment of dry cannabis to Germany, the biggest medical-cannabis market in Europe.

The leadership at these companies had the vision to use legal clarity… and coffers full of cash… to start building out a global footprint that’ll be hard to beat even when competition heats up.

But here’s the really great part: The stocks of these international plays are priced in a way that barely reflects any share of the global market at all; it’s as if investors were convinced that Nike Inc. (NYSE: NKE) was just a trendy shoe boutique with five locations, as opposed to a $29.6 billion multinational. The way they’re trading, it would seem the equity markets only focus lies on the United States. It’s shortsighted, to say the least.

To call these “bargains” is almost a ridiculous understatement. After all, the global cannabis market represents a $4 trillion opportunity, and these companies are first in line.

New Cannabis Lots Can Turn a Small Stake into $15,424 in Just Days

In the past few months, a new way to make money off the cannabis market has unfolded – a strategy that our data shows could turn a small stake into $15,424 in just four days.

Now, this is different from traditional stock trading.

In fact, it would’ve taken 20 times the initial investment to see that kind of payday on a stock… and although this idea is new in the world of cannabis investing, it’s a system that’s been around since Ancient Greece.

To find out how you can take this sort of profit potential into your hands, just click here.

Follow Money Morning onFacebook and Twitter.

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.

Disclaimer: © 2019 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.